Building A Go-To-Market Strategy with Value for All Players & Stakeholders in Rare Disease
Time: 8:00 am - 10:00 am
day: Pre-Conference Workshop Day
Details:
Unlike traditional pharmaceuticals, rare disease commercialization requires a deeply specified roadmap, where patient engagement, access strategies, and regulatory navigation must be customized to the nuances of each disorder, making templated approaches ineffective.
- How to plan and create road maps to a successful commercial strategy
- How best to assess treatment guidelines, current treatments & regulations to inform early strategy
- How to quality check commercial strategy planning to ensure success further down the line
- Learning from past successes and failures in rare disease commercialization to refine forecasting and strategic decision-making
